Betalife: рассеянный склероз

62
Betalife: рассеянный склероз is an Android app from BIOCAD in the Health & Fitness category, currently rated 4.9★ across 397 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 62: Solid (established niche player). For a Health & Fitness app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Health & Fitness complexity ×1.40 | +$20K |
| 🌐 Cross-platform reach (iOS + Android) | +$38K |
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
| 📲 Health & Fitness engagement | ~70 installs / rating |
| 🔁 Health & Fitness D30 retention | 22% |
| 📍 DAU / MAU stickiness | 0.35 |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Early-stage solo · 42/100INDIE TIERexpected for tier- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.91★ across 397 reviews — solid.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| Excellent rating (4.9★)METRIC | +$2,200 | |
| Established app (5y old)METRIC | +$800 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Early-stage install base (397 ratings)METRIC | +$400 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- Betalife: рассеянный склероз
- Developer
- BIOCAD
- Bundle ID
- com.betalife
- App Store URL
- Open in App Store
- Category
- Health & Fitness
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- betalife.ru
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $115/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📈Ratings growth397 ratings+78% lifetimeShow 3-year history estimate ▾
📝 About this app
Monitor your health, note medications and symptoms. Monitor exacerbations and their relationship to treatment. Monitor your activity and diet.
Communicate via chat or personal dialogues. Share your experiences and support each other.
Fill out the diary regularly and watch how statistics are collected and your interactive tree grows in the application!… View full description on the official store →
Tech & Domain Intel — betalife.ru
- Tech stack
- Microsoft 365
Track this app’s revenue
FREE📝 Description
95
More by BIOCAD
View all →Why medium confidence: 397 ratings · no founder-verified revenue (model estimate only).




